137 related articles for article (PubMed ID: 22985558)
1. [Expressions of peroxiredoxin 1, peroxiredoxin 6 and GFAP in human brain astrocytoma and their clinical significance].
Zhou J; Liu Q; Wang J; Guo X; Song L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1255-9. PubMed ID: 22985558
[TBL] [Abstract][Full Text] [Related]
2. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
[TBL] [Abstract][Full Text] [Related]
3. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of the expression of the RCAS1 mRNA and protein in astrocytic tumors].
Shen CF; Yuan XR; Qin ZQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):836-9. PubMed ID: 18007080
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological study on malignant glioma--with special reference to GFAP].
Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
[TBL] [Abstract][Full Text] [Related]
6. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
Korshunov AG; Sycheva RV
Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
[TBL] [Abstract][Full Text] [Related]
7. Expression and release of CD14 in astrocytic brain tumors.
Deininger MH; Meyermann R; Schluesener HJ
Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
[TBL] [Abstract][Full Text] [Related]
8. Variability of intracellular concentrations of basic fibroblast growth factor in cultured human gliomas.
Welch WC; Kornblith PL; Zimmerman HM; Bradley MK
In Vivo; 1999; 13(2):109-18. PubMed ID: 10363165
[TBL] [Abstract][Full Text] [Related]
9. Diversity of glial cell components in pilocytic astrocytoma.
Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
[TBL] [Abstract][Full Text] [Related]
10. Expression of neuronal markers, NFP and GFAP, in malignant astrocytoma.
Hashemi F; Naderian M; Kadivar M; Nilipour Y; Gheytanchi E
Asian Pac J Cancer Prev; 2014; 15(15):6315-9. PubMed ID: 25124617
[TBL] [Abstract][Full Text] [Related]
11. Morphometrical analysis of GFAP-positive cells in human astrocytomas.
Yoshii Y; Narushima K; Tsurushima H; Yanaka K; Hyodo A; Nose T; Sugiyama K; Sakamura S
Neurol Med Chir (Tokyo); 1992 Jul; 32(8):554-8. PubMed ID: 1383844
[TBL] [Abstract][Full Text] [Related]
12. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
Chen Y; Zhang YX
Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
[TBL] [Abstract][Full Text] [Related]
13. Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity.
Rutka JT; Smith SL
Cancer Res; 1993 Aug; 53(15):3624-31. PubMed ID: 8339269
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].
Wang DL; Wang YF; Shi GS; Huang H
Ai Zheng; 2007 Jun; 26(6):601-6. PubMed ID: 17562265
[TBL] [Abstract][Full Text] [Related]
15. [Expression of peroxiredoxin 6 in gastric cancer and its clinical significance].
Guo HW; Lü YY; Zhu YL; Yang GB
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2433-5. PubMed ID: 23158669
[TBL] [Abstract][Full Text] [Related]
16. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional significance of ezrin in human brain astrocytoma.
Mao J; Yuan XR; Xu SS; Jiang XC; Zhao XT
Cell Biochem Biophys; 2013; 67(3):1507-11. PubMed ID: 23712870
[TBL] [Abstract][Full Text] [Related]
18. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells.
Rutka JT; Hubbard SL; Fukuyama K; Matsuzawa K; Dirks PB; Becker LE
Cancer Res; 1994 Jun; 54(12):3267-72. PubMed ID: 8205549
[TBL] [Abstract][Full Text] [Related]
19. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression.
Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M
Oncogene; 2003 May; 22(22):3407-11. PubMed ID: 12776191
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the RNA-binding motif protein 3 in human astrocytoma.
Zhang HT; Zhang ZW; Xue JH; Kong HB; Liu AJ; Li SC; Liu YX; Xu DG
Chin Med J (Engl); 2013; 126(10):1948-52. PubMed ID: 23673116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
